Michael E Green, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 854 Lone Oak Drive, Gallatin, TN 37066 Phone: 615-452-1602 Fax: 615-451-0139 |
News Archive
Idera Pharmaceuticals, Inc. today presented new data on its novel gene-silencing oligonucleotide (GSO) technology at the Cell Symposium on Regulatory RNAs in Chicago, IL.
Genzyme Corp. and Isis Pharmaceuticals Inc. announced that data from the phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia (heFH) were presented today at the European Society of Cardiology's Congress 2010 in Stockholm, Sweden. The study met its primary endpoint with a 28 percent reduction in LDL-cholesterol, compared with an increase of 5 percent for placebo (p<0.001). The trial also met all of its secondary and tertiary endpoints.
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group announced today the results of a clinical trial of its investigational Fluzone Quadrivalent (Influenza Virus Vaccine) compared to the currently licensed Fluzone (Influenza Virus Vaccine). Data from the Phase II trial assessing the immunogenicity and safety of the investigational quadrivalent vaccine were presented at the 48th Annual Meeting of the Infectious Diseases Society of America in Vancouver, British Columbia.
Winter recreational activities can pose painful problems for the outdoor enthusiast who is not in the best condition. Preparing your body before participating in winter sports such as snowboarding, skiing or ice-skating decreases the potential for spasms, strains and sprains, according to the American Chiropractic Association.
› Verified 1 days ago